Telomir Pharmaceuticals Announces New Data Showing That Telomir-1 Kills Aggressive Pancreatic Cancer Cells, One of the Deadliest Forms of Cancer

Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1's consistent impact on cancer cell survival pathways.
MIT Technology Review

How aging clocks can help us understand why we age—and if we can reverse it

A person who develops age-related diseases earlier in life, or has other biological changes associated with aging (such as ...
Study Finds

She Lived To 117. Here’s How The World’s Oldest Woman’s Cells Stayed Decades Younger Than Her Age

Study of Maria Branyas Morera found a youth-leaning gut, low inflammation, rare genes, and slower DNA-based aging—offering ...

Telomir Pharmaceuticals Announces New Findings in a Prostate Cancer Model Demonstrating Telomir-1 Also Resets DNA Methylation of Tumor Suppressor Genes Implicated in Two of the ...

Findings show that Telomir-1 restores the body’s natural tumor suppressor defenses by reversing abnormal DNA methylation of MASPIN and RASSF1A – genes that help block invasion, limit metastasis, and ...